How to obtain ethical approval for a study involving deceased patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Obtaining Ethical Approval for Research Involving Deceased Patients

Obtain IRB approval by submitting a research protocol that addresses privacy protections, family notification procedures, and demonstrates scientific value, while recognizing that consent requirements differ based on whether you are using newly deceased patients for training/procedures versus conducting retrospective research on data from deceased patients. 1

Key Distinction: Type of Research Determines Approach

For Retrospective Research Using Data/Records from Deceased Patients

Submit your protocol to the Institutional Review Board (IRB) emphasizing that the research involves minimal risk and requesting a waiver of informed consent. 1

  • The IRB can approve research on deceased patients' data without family consent if the study has scientific value and protects patient privacy. 1
  • You must demonstrate compliance with HIPAA regulations for protecting health information and medical records, even for deceased patients. 1
  • Minimize collection of personal health information and implement strict confidentiality protections in your protocol. 1
  • Document that obtaining consent from families is impracticable and would not alter the minimal risk nature of the research. 1

For Research/Training Using Newly Deceased Bodies

Obtain consent from family members before using newly deceased patients for training or research purposes—this is the ethical standard that should prevail. 1

The American Heart Association guidelines are explicit on this point:

  • "Ultimately, the respect for the individual should prevail over the need for healthcare providers to practice lifesaving techniques." 1
  • Obtaining consent from family members shows respect for the newly dead patient and surviving family members. 1
  • Arguments for presumed consent based on "greater good" fail to adequately weigh potential harm to surviving family members who may oppose such use. 1
  • Cultural differences in acceptance of cadaver use in medical education must be respected. 1

Required IRB Application Components

Your IRB application must include these specific elements: 1

  • Scientific rationale demonstrating social and scientific value of the research (i.e., does it matter and will it advance knowledge?) 1
  • Risk-benefit analysis showing risks are minimized and reasonable 1
  • Fair participant selection criteria 1
  • Privacy and confidentiality protections, including HIPAA compliance 1
  • Procedures for family notification if using newly deceased patients 1, 2
  • Data safety and monitoring procedures 1

Special Considerations for Deceased Patient Research

Develop institutional protocols in advance that address: 2

  • Processes for obtaining permission from families when applicable 2
  • Guidelines for procurement of tissues or data 2
  • Information about applicable laws and societal values 2
  • Emotional support mechanisms for family members and healthcare providers 2

Common Pitfalls to Avoid

Do not assume deceased patients have no privacy rights—HIPAA protections continue after death. 1

Do not proceed with presumed consent for using newly deceased bodies without IRB approval and institutional protocols. 1

Do not conflate organ/tissue donation protocols with research protocols—while related, research requires separate IRB approval. 2

Ensure your IRB has appropriate expertise to evaluate your specific type of research involving deceased patients. 1

Timeline Expectations

Plan for IRB review to take weeks to months, with potential for multiple submissions. 1

  • Emergency research protocols using exception from informed consent have taken up to 404 days (median 108 days) and up to 7 submissions for approval. 1
  • Standard retrospective research typically requires less time but still plan for iterative review. 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Managing Sperm/Ova Retrieval Requests from Brainstem Death Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.